The End of Aging? World's First Anti-Aging Gene Therapy Begins!

Title:- The End of Aging? World's First Anti-Aging Gene Therapy Begins! The world's first anti-aging gene therapy has officially entered human trials. In June 2026, Life Biosciences announced that the first patient received ER-100, an experimental gene therapy designed to restore youthful cellular function using partial epigenetic reprogramming and Yamanaka factors. But this is only the beginning. Scientists are now exploring CRISPR gene editing, senolytic drugs, stem cell therapies, regenerative medicine, AI-powered drug discovery, and age-reversal technologies that could dramatically extend human healthspan. Could we one day reset our biological age? Will anti-aging therapies become available to everyone, or only the ultra-wealthy? And how close are we really to slowing—or even reversing—human aging? In this episode of Tech Machine, Shreya explores the cutting-edge science behind longevity, age reversal, gene therapy, AI-driven medicine, and the future of human health. Topics Covered: • ER-100 Anti-Aging Gene Therapy • Yamanaka Factors • Epigenetic Reprogramming • Cellular Senescence (Zombie Cells) • CRISPR Gene Editing • Senolytic Drugs • Stem Cell Therapy • Organ Regeneration • AI Drug Discovery • Biological vs Chronological Age • Longevity Science • Future of Human Aging Subscribe to Tech Machine for breakthrough science, emerging technologies, AI, biotechnology, space exploration, and the future of humanity. #TechMachine #AntiAging #GeneTherapy #Longevity #FutureTechnology Please note AI generated images are used in this video.